Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
Karpiak explains how her flexible schedule enables her to succeed at work while staying active in her community.
For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.